News

Filter

Licensing deals between Xenon and Isis for XEN701, and Access and AMAG for MuGard

10-06-2013

USA-based Isis Pharmaceuticals (Nasdaq: ISIS) revealed that privately-held Canadian firm Xenon Pharmaceuticals…

Access PharmaceuticalsAMAG PharmaceuticalsIsis PharmaceuticalsLicensingMuGardNephrology and HepatologyOncologyPharmaceuticalXEN701Xenon Pharmaceuticals

US deal for Vectura; takeover bid for AMAG

03-08-2011

There was good news this morning from Vectura Group (LSE: VEC), a UK-based inhalation product development…

Allos TherapeuticsAMAG PharmaceuticalsLicensingMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryVectura

COMPANY SPOTLIGHT

Menarini

Back to top